David M Stack is CEO and Chairman of Pacira BioSciences, Inc.. Currently has a direct ownership of 186,481 shares of PCRX, which is worth approximately $3.1 Million. The most recent transaction as insider was on Jun 14, 2023, when has been sold 32,700 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 186K
0% 3M change
0% 12M change
Total Value Held $3.1 Million

DAVID M STACK Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 14 2023
BUY
Grant, award, or other acquisition
-
32,700 Added 14.92%
186,481 Common Stock
Jun 07 2023
SELL
Open market or private sale
$201,695 $37.87 p/Share
5,326 Reduced 3.35%
153,781 Common Stock
Jun 06 2023
SELL
Open market or private sale
$197,211 $38.99 p/Share
5,058 Reduced 3.08%
159,107 Common Stock
Jun 08 2022
SELL
Open market or private sale
$839,083 $60.68 p/Share
13,828 Reduced 8.86%
142,251 Common Stock
Jun 08 2022
BUY
Grant, award, or other acquisition
-
21,500 Added 11.61%
163,751 Common Stock
Jun 06 2022
SELL
Open market or private sale
$734,292 $61.37 p/Share
11,965 Reduced 7.12%
156,079 Common Stock
Apr 28 2022
BUY
Exercise of conversion of derivative security
$243,225 $10.81 p/Share
22,500 Added 11.81%
168,044 Common Stock
Mar 31 2022
BUY
Exercise of conversion of derivative security
$243,225 $10.81 p/Share
22,500 Added 13.39%
145,544 Common Stock
Jan 25 2022
BUY
Exercise of conversion of derivative security
$147,773 $10.81 p/Share
13,670 Added 10.0%
123,044 Common Stock
Jan 11 2022
BUY
Exercise of conversion of derivative security
$162,150 $10.81 p/Share
15,000 Added 12.06%
109,374 Common Stock
Nov 16 2021
BUY
Exercise of conversion of derivative security
$162,150 $10.81 p/Share
15,000 Added 13.75%
94,085 Common Stock
Jun 09 2021
BUY
Grant, award, or other acquisition
-
17,800 Added 18.4%
78,956 Common Stock
Jun 04 2021
SELL
Open market or private sale
$909,801 $61.04 p/Share
14,905 Reduced 19.6%
61,156 Common Stock
May 12 2021
SELL
Open market or private sale
$1,312,188 $61.75 p/Share
21,250 Reduced 21.84%
76,061 Common Stock
May 12 2021
BUY
Exercise of conversion of derivative security
$229,713 $10.81 p/Share
21,250 Added 17.92%
97,311 Common Stock
May 11 2021
SELL
Open market or private sale
$1,295,825 $60.98 p/Share
21,250 Reduced 21.84%
76,061 Common Stock
May 11 2021
BUY
Exercise of conversion of derivative security
$229,713 $10.81 p/Share
21,250 Added 17.92%
97,311 Common Stock
Feb 03 2021
SELL
Open market or private sale
$1,510,875 $71.1 p/Share
21,250 Reduced 21.84%
76,061 Common Stock
Feb 03 2021
BUY
Exercise of conversion of derivative security
$229,713 $10.81 p/Share
21,250 Added 17.92%
97,311 Common Stock
Feb 02 2021
SELL
Open market or private sale
$1,473,263 $69.33 p/Share
21,250 Reduced 21.84%
76,061 Common Stock
Feb 02 2021
BUY
Exercise of conversion of derivative security
$229,713 $10.81 p/Share
21,250 Added 17.92%
97,311 Common Stock
Oct 16 2020
SELL
Open market or private sale
$1,666,800 $55.56 p/Share
30,000 Reduced 14.75%
173,377 Common Stock
Oct 16 2020
BUY
Exercise of conversion of derivative security
$324,300 $10.81 p/Share
30,000 Added 12.85%
203,377 Common Stock
Oct 15 2020
SELL
Open market or private sale
$1,650,000 $55.0 p/Share
30,000 Reduced 14.75%
173,377 Common Stock
Oct 15 2020
BUY
Exercise of conversion of derivative security
$324,300 $10.81 p/Share
30,000 Added 12.85%
203,377 Common Stock

Also insider at

AMRN
AMARIN CORP PLCUK Healthcare
DMS

David M Stack

CEO and Chairman
Tampa, FL

Track Institutional and Insider Activities on PCRX

Follow Pacira BioSciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PCRX shares.

Notify only if

Insider Trading

Get notified when an Pacira Bio Sciences, Inc. insider buys or sells PCRX shares.

Notify only if

News

Receive news related to Pacira BioSciences, Inc.

Track Activities on PCRX